Company Filing History:
Years Active: 2013
Title: Sierra Lee Jones Collier: Innovator in Anti-CGRP Antagonist Antibodies
Introduction
Sierra Lee Jones Collier is a prominent inventor based in Menlo Park, California. She has made significant contributions to the field of biotechnology, particularly in the development of methods for treating CGRP-associated disorders. Her innovative work has the potential to improve the quality of life for many individuals suffering from various types of headaches and vasomotor symptoms.
Latest Patents
Sierra Lee Jones Collier holds a patent for "Methods of using anti-CGRP antagonist antibodies." This invention features methods for preventing or treating CGRP-associated disorders, including migraines, cluster headaches, tension headaches, and hot flushes. The patent describes the administration of an anti-CGRP antagonist antibody, specifically the antagonist antibody G1 and its derivatives directed to CGRP.
Career Highlights
Collier is currently associated with Labrys Biologics, Inc., where she continues to advance her research and development efforts. Her work at Labrys Biologics focuses on innovative solutions for treating neurological conditions, showcasing her commitment to improving patient outcomes through scientific advancements.
Collaborations
Sierra Lee Jones Collier collaborates with notable colleagues, including Joerg Zeller and Kristian Todd Poulsen. These partnerships enhance her research capabilities and contribute to the development of groundbreaking therapies in the field.
Conclusion
Sierra Lee Jones Collier is a trailblazer in the biotechnology sector, with her patent on anti-CGRP antagonist antibodies representing a significant advancement in the treatment of headache disorders. Her dedication to innovation and collaboration continues to drive progress in this vital area of healthcare.